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AbstrACt
Introduction Global actions to reduce antimicrobial 
resistance (AMR) include optimising the use of 
antimicrobial medicines in human and animal health. In 
countries with weak healthcare regulation, this requires 
a greater understanding of the drivers of antibiotic use 
from the perspective of providers and consumers. In 
Bangladesh, there is limited research on household 
decision-making and healthcare seeking in relation to 
antibiotic use and consumption for humans and livestock. 
Knowledge is similarly lacking on factors influencing the 
supply and demand for antibiotics among qualified and 
unqualified healthcare providers. The aim of this study 
is to conduct integrated research on household decision-
making for healthcare and antibiotic use, as well as 
the awareness, behaviours and priorities of healthcare 
providers and sellers of antibiotics to translate into policy 
development and implementation.
Methods and analysis In-depth interviews will be 
conducted with (1) household members responsible for 
decision-making about illness and antibiotic use for family 
and livestock; (2) qualified and unqualified private and 
government healthcare providers in human and animal 
medicine and (3) stakeholders and policy-makers as key 
informants on the development and implementation of 
policy around AMR. Participant observation within retail 
drug shops will also be carried out. Qualitative methods 
will include a thematic framework analysis. A holistic 
approach to understanding who makes decisions on the 
sale and use of antibiotics, and what drives healthcare 
seeking in Bangladesh will enable identification of routes 
to behavioural change and the development of effective 
interventions to reduce the health risks of AMR.
Ethics and dissemination Approval for the study has 
been obtained from the Institutional Review Board at the 
International Centre for Diarrhoeal Disease Research, 
Bangladesh following review by the Research and 
Ethics Committees (PR-16100) and from Loughborough 
University (R17-P081). Information about the study will 
be provided in a participant information letter in Bangla 
(to be read verbally and given in writing to participants). A 
written informed consent form in Bangla will be obtained 
and participants will be informed of their right to withdraw 
from the study. Dissemination will take place through 
a 1 day dissemination workshop with key stakeholders 
in public health and policy, practitioners and scientists 
in Bangladesh, and through international conference 
presentations and peer-review publications. Anonymised 
transcripts of interviews will be made available through 
open access via institutional data repositories after an 
embargo period.
IntroduCtIon 
The availability of over-the-counter antibi-
otics for humans and animals, and a lack 
of training and compliance with standards 
among healthcare providers (HCPs) are 
important contributors to the emergence 
of antibiotic resistance in Bangladesh and 
other emerging economies.1 Understanding 
the behaviour and priorities of HCPs, and 
the needs of consumers is therefore central 
to developing an effective strategy to tackle 
antimicrobial resistance (AMR). While there 
is clear evidence of inappropriate prescribing 
and use of antibiotics,1–3 universal access to 
healthcare is also an important consideration 
in countries with inadequate healthcare infra-
structure. In this context, retail drug shops 
and private providers play a critical role in 
meeting the health needs of the population, 
particularly among the poorer sectors of 
society.4–7 
strengths and limitations of this study
 ► The study will provide qualitative insights into anti-
biotic dispensing and sales practices across a range 
of qualified and unqualified providers.
 ► A One Health approach to antimicrobial resistance 
will be employed to investigate healthcare deci-
sion-making for illness in humans and their live-
stock or animals.
 ► The study will highlight the healthcare needs of 
poor and economically disadvantaged groups in 
Bangladesh.
 ► As formative research in one rural and one urban 
site, the sample may not represent all communi-
ty-level healthcare providers in Bangladesh.
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Bangladesh has an estimated 100 000 licensed retail 
drug shops and a further 100 000 unlicensed drug shops 
selling prescription-only drugs including antibiotics.4 
Unqualified providers are the major providers of health-
care for the poor and disadvantaged.8 Within primary 
healthcare, a high proportion of all consultations result 
in a prescription for antibiotics: 44% of consultations in 
Bangladesh5 and 70% of consultations in Pakistan9 are 
reported to result in antibiotic prescribing. Within retail 
drug shops, the majority of antibiotics are purchased 
without a prescription.4 In Tanzania, accredited drug 
dispensers knew the effects of unnecessary antibiotic 
use, but their practices were driven by customer demand, 
habits and profit.7 Antibiotics provided to patients 
without a prescription are likely to be a less appro-
priate drug, taken for an incorrect duration (course), 
or of the wrong dose.10 Unqualified drug sellers also 
fall victim to aggressive marketing strategies resulting in 
overprescribing, multidrug prescribing, using unneces-
sarily expensive drugs and dispensing drugs without a 
prescription.4
Children and older adults make up a large proportion 
of people seeking treatment and receiving antibiotics. 
In Bangladesh, 27% of patients attending rural health 
centres and 40% at urban centres were under 5 years 
of age.5 Other studies reported that antibiotic prescrip-
tions were most often issued for children aged 0–15 years 
(35%) followed by adults aged over 60 years (23%).2 
Polypharmacy, the prescribing of 3 or more drugs, is also 
common (46% in urban centres, 33% in local health 
centres).5
In response to global actions to reduce AMR, Bangla-
desh is in the early stages of implementing the National 
Action Plan on AMR,11 has undertaken a situation analysis 
on AMR containment12 and has also developed a Model 
Pharmacy programme.13 These national developments 
highlight the importance of understanding behaviours 
that may facilitate or hinder effective implementation and 
reductions in antibiotic use. Our research can provide 
valuable insights to support further development of the 
model pharmacy initiative.
The aim of the study therefore is to take a holistic 
approach to determine current dispensing, purchase, 
use and consumption of antibiotics through formal 
and informal sectors for both humans and animals in 
Bangladesh.
The specific objectives of the research are:
1. To understand the pathways of antibiotic use within 
households from the onset of illness to the purchase 
and consumption of antibiotics.
2. To examine the role of qualified and unqualified pri-
vate providers and government primary care health 
service providers in antibiotic prescribing and sales.
3. To inform government policy and identify pathways 
to behavioural change among HCPs, livestock owners 
and people or patients who use antibiotics.
MEthods And AnAlysIs
terminology and definitions of hCPs and sellers of antibiotics
The pluralistic health system in Bangladesh provides 
multiple avenues of healthcare provision. One system of 
categorising HCPs is by formal or informal sector provi-
sion, whereby informal refers to HCPs who are not regis-
tered with a government regulatory authority.8 However, 
this does not make a clear distinction between the 
different levels of training within the informal sector. For 
example, family health workers in Bangladesh fall within 
the informal sector yet are employed by the govern-
ment/public health system and may undergo significant 
training. Other providers in the informal sector such as 
unqualified ‘village’ or ‘quack’ doctors have no formal 
training. Within retail drug shops, there is also variation 
in the qualification of providers. In a representative survey 
in Bangladesh, only 51% of drug shops were staffed by a 
trained pharmacist with the remaining having no formal 
training. Of those who were trained, 91% had only the 
minimum qualification (12-week training certificate).4 
Based on our pilot work and previous research,8 therefore, 
we identified four main groups of antibiotic providers in 
human and animal health within the allopathic medical 
system to reflect the pluralistic health system in Bangla-
desh.14 These are: qualified medical or veterinary gradu-
ates; auxiliary medical professionals; semiqualified HCPs 
and unqualified HCPs (table 1). A range of terms are 
also used for outlets that sell or dispense antibiotics. For 
this study, we employ the term ‘drug shop’, operationally 
defined as ‘a private retail pharmacy or drug store eligible 
for mandatory approval and registration from the Direc-
torate General of Drug Administration (DGDA)’.4 Some 
literature refers to these outlets in Bangladesh as phar-
macies, defined as ‘establishments that sell drugs with or 
without a doctor’s prescription to the general public’.15 
Table 1 Categories of qualified and unqualified healthcare 
providers involved in prescribing, dispensing or selling 
antibiotics in Bangladesh
Type of provider
Medical and 
veterinary Pharmacy
Qualified graduate 
practitioner
Bachelor in medicine, 
bachelor in surgery; 
doctor of veterinary 
medicine
Category A 
pharmacists 
(MPharm, 
BPharm)
Auxiliary medical/
veterinary 
professionals
Diploma in medicine 
or any health-related 
subject, 1–4 years 
training 
Category B 
pharmacists 
(Diploma)
Semiqualified 
healthcare 
provider
Less than 1-year 
training
Category C 
pharmacists 
(12-week 
training 
certificate)
Unqualified 
healthcare 
provider
No health-related 
training
None
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We use drug shop rather than pharmacy, however, to 
reflect the individual, privatised and unregulated nature 
of many retail outlets of antibiotics in Bangladesh.
study site
The rural sample site for the selection of households 
and HCPs is in Mirzapur upazila (subdistrict) of Tangail 
district. The urban site is in nearby Tongi upazila (subdis-
trict) of Gazipur district. In both locations, we will select 
areas that have not been included in any communi-
ty-based interventions or health surveys. Data collection 
started in May 2017 and is nearing completion.
Patient and public involvement
As this is a community-based study, we have not involved 
patient groups in the study design or research protocol. 
However, the study team has consulted key personnel 
in the local government medical and veterinary posts at 
the rural site (Government Livestock Office and Upazila 
Health Complex). Similarly, in the urban site, we met 
with the government health department within the Tongi 
City Corporation to identify appropriate recruitment 
methods, gain approval to interview government staff and 
to inform them of the nature of the research. Community 
representatives were consulted before any recruitment of 
households to the study.
objective 1: pathways of antibiotic use within households
In-depth interviews will collect information on the intra-
household use of antibiotics including who obtains the 
antibiotics, on behalf of which family members or live-
stock; who consumes the antibiotics; how and when anti-
biotics are obtained and at what cost; for what purpose/
illness the antibiotics are used. We will explore beliefs 
and understandings that drive antibiotic consump-
tion to better understand healthcare seeking decisions; 
perceptions of susceptibility and health risk, particu-
larly for vulnerable household members; and attitudes 
towards treatment with antibiotics including beliefs about 
efficacy and quality. We will establish who makes deci-
sions and what drives healthcare seeking and antibiotic 
consumption.
selection and recruitment of participants for household 
interviews
We will purposively select households with dependents 
(children under 5 years and older adults) and livestock 
(in rural areas) and interview either the household 
member that makes key decisions around healthcare 
seeking or the primary caregiver of children and depen-
dents. We will use a combination of random household 
sampling and discussion with community members to 
identify households to approach.
We will sample from two socioeconomic strata using 
a threshold monthly income of less than or greater 
than Taka 15 000 (approximately GBP150) in rural 
areas and Taka 20 000 (GBP200) in urban areas, based 
on the national midrange of household income16 
to gain insights into socioeconomic influences on 
decision-making. We will seek maximum variation 
in the social context of the sample, including purpo-
sive sampling of households from the minority ethnic 
indigenous population in rural areas. Where anyone in 
the household is unwell with symptoms of diarrhoea, 
fever or respiratory problems, we will request consent 
to recontact the household for a follow-up interview 
to understand how their illness had progressed and 
what healthcare was sought. We will aim to identify up 
to 12 households with a currently ill member thereby 
gaining a longitudinal dimension on the outcomes of 
health-seeking and treatment. Table 2 provides recruit-
ment targets per strata with a total target sample size of 
48 household interviews. This will be reviewed as data 
collection proceeds in line with qualitative data collec-
tion methods and the team’s experience to ensure that 
data saturation is reached.17
objective 2: pathways of antibiotics prescribing and selling by 
qualified and unqualified hCPs
In-depth interviews with qualified, auxiliary, semiqualified 
and unqualified HCPs will examine prescribing practices 
as well as exploring the needs and demands of customers, 
the influence of medical representatives and drug manu-
facturers and the need of drug sellers and providers to 
maintain a livelihood in settings where training may be 
unavailable or the cost of licensing unaffordable.4 We will 
explore cultural norms and beliefs about the efficacy of 
antibiotics and knowledge surrounding the development 
of antibiotic resistance among all groups interviewed.
Table 2 Sampling frame for household interviews about 
decision-making around healthcare seeking, antibiotic 
purchasing and consumption
Rural
(total n=24)
Urban
(total n=24)
<15 000 
Taka*
(n=12)
>15 000 
Taka
(n=12)
<20 000 
Taka
(n=12)
>20 000 
Taka
(n=12)
Households 
with 
child<5 years
9 9 9 9
Households 
with older 
family member†
6 6 6 6
Households 
with a currently 
ill member
3 3 3 3
Indigenous 
ethnic 
households
2 2 0 0
*Monthly household income in Bangladesh Taka.
†Considered as women aged >62 years and men aged >65 years 
old; eligibility threshold to receive government old age allowance in 
Bangladesh.
 o
n
 26 February 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-028215 on 25 January 2019. Downloaded from 
4 Rousham EK, et al. BMJ Open 2019;9:e028215. doi:10.1136/bmjopen-2018-028215
Open access 
selection and recruitment of hCPs
To maximise diversity, a critical element of qualitative 
research,18 we will sample from four categories of HCPs 
outlined in table 3. The HCPs will mirror the locations, 
types of providers (public/government and private) 
and antibiotic outlets in the study areas. We will recruit 
community HCPs from central district medical and veter-
inary facilities, local government facilities, and village-
level HCPs in order to capture geographical variation in 
human and animal medicine providers. The combina-
tion of data collection methods will allow triangulation 
of findings from the different sources of information. A 
target sample of 46 HCPs will be interviewed to continue 
until data saturation is reached. This sample strategy is 
based on a grounded theory approach.18 19
drug shop observations
Ethnographic observations will be carried out in 
eight retail drug shops to capture interactions between 
the antibiotic dispensers or sellers and their clients 
in a range of settings. Two observation periods, each 
of 2 hours duration, per outlet will take place in the 
morning (09:00–11:00) and evening (16:00–18:00) to 
capture variations in customers at different times of 
day. The drug shops recruited will include those selling 
humans medicine, animal medicine and both. As well 
as observing the seller–customer interactions, we will 
record the presence of a doctor’s chamber within the 
premise, whether patients visited/purchased antibiotics 
themselves, whether customers bought antibiotics with or 
without prescription and the advice and guidance given 
to customers.
objective 3: key informant interviews and intervention 
development workshop
Policy review and key informant interviews
A desk-based review using systematic search methods 
will be conducted to identify relevant policy documents 
and regulations to contain AMR from a One Health 
perspective. Attention will also be given to regional 
policy and the situation in Bangladesh in relation to the 
South and South East Asia regions. Following the review, 
we will conduct key informant interviews to understand 
existing incentives to drug shops, the role of the phar-
maceutical industry in preventing antibiotic resistance 
and what information is needed by government to bring 
about behavioural change. Interviews will take place with 
Government representatives, pharmaceutical industry 
and medical representatives, regulatory authority 
members responsible for licensing and representatives of 
national or multinational agencies. A total of 35 key infor-
mant interviews will be carried out.
Informing and developing interventions
Following the formative data collection, a 1 day inter-
vention development workshop will be held to present 
preliminary research findings, and potential options 
for intervention or improving current practices around 
antibiotic sales and use. The workshop will include 
stakeholders, clinicians (human and animal) and drug 
shop owners. Based on the analysis of the qualitative 
assessments, the observations and input from the work-
shop participants, the study team, in association with a 
professional communication team, will develop tailored 
behavioural change messages and materials around the 
appropriate use of antibiotics. Messages will be produced 
to incorporate different media including text, audio 
and video. We will take professional help from a creative 
agency in the appropriate intervention delivery methods 
and message development that includes compelling 
design and depiction.
We will pretest the messages that have been developed 
for the key target audience(s) to assess their appropriate-
ness and value. Feedback will be collected using an open-
ended questionnaire 1 week after delivering the messages 
in association with the communication professionals. The 
creative agency, in collaboration with the research team, 
will revise the pilot communication materials and take 
this work forward for further research proposals.
Methodological approaches
Analytical methods will be drawn from behavioural science 
and social anthropology. The analysis of household deci-
sion-making behaviours will highlight the illnesses, symp-
toms, risk perceptions and household dynamics that lead 
individuals and carers to seek medical advice and treat-
ment for themselves or others. The views and practices 
of providers of antibiotics will be explored by applying 
the ‘social lives of medicines’ theory as an anthropolog-
ical concept. Whyte et al 20 propose that medicines also 
have social lives that incorporate their production and 
marketing, their prescription, their distribution through 
intertwined formal and informal channels, their deaths 
through one or another form of consumptions and finally 
their after death in the form of efficacy in modifying 
bodies. The framework will enable conceptualisation of 
antibiotic prescribing behaviour and use, and knowledge 
Table 3 Sampling frame for in-depth interviews with 
qualified and unqualified healthcare providers
Category Type of provider Rural Urban Total
Qualified graduate 
practitioner
Public and 
private; human 
and veterinary 
medicine
5 5 10
Auxiliary medical 
professionals*
Healthcare 
workers, 
paramedics
4 4 8
Semiqualified 
healthcare 
provider
Retail drug shop 
owner or seller
7 7 14
Unqualified 
healthcare 
provider
Retail drug shop 
owner or seller
7 7 14
Total 23 23 46
*Provider in human medicine only, no veterinary equivalent.
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of antibiotic resistance from the perspective of both 
providers and household members.
Interviews will be conducted in Bangla, audio recorded 
and transcribed in full in Bangla. Any identifying char-
acteristics of participants, individuals or private practices 
will be anonymised.
data analysis
Translation
The challenges of translation of qualitative research are 
summed up as: ‘translating the participant’s narrative 
data, which could yield colloquial source language and 
nuances, to a professional style in a different language; 
this may impose difficulties when trying to reduce the gap 
between different languages.’21 On this topic, Twinn22 
establishes empirically (using a small number of inter-
views in Chinese or translated into English) that although 
little difference to the main themes emerges, important 
differences in the detailed material are apparent, particu-
larly where differences in language structure made trans-
lation more challenging. Generally, later translation to 
English is preferred where most of the researchers are 
non-English speaking.23
In this study, the team comprises English, non-En-
glish speaking and some bilingual researchers. Our 
decision about how much to translate and at what point 
also reflects the pragmatic constraints of cost and time 
resources.24 For quality assurance reasons, we aim to keep 
transcription and translation within the core study team 
as much as possible, ensuring a shared understanding of 
study aims and approach.25 26
Our chosen solution is to translate one-third of tran-
scripts in full into English, by native Bangla researchers. 
The translated transcripts will reflect the variety of our 
samples and will be used as the basis for the framework for 
analysis. The remaining Bangla transcripts will be coded 
in Bangla, and then the text in the framework will be 
translated into English. This method will allow the whole 
team (including non-Bangla speakers) to contribute to 
the development of the analysis structure and first draft 
analysis, while allowing the early analyses to be conducted 
in Bangla.23 27 28
Analysis
A framework analysis will be applied to the qualitative 
interview data.29 A framework analysis involves case- and 
theme-based approaches, with matrix display and data 
reduction through summarisation and synthesis. This 
method retains links to the original data and the output 
allows comprehensive and transparent data analysis. 
The framework analysis will be based on the principle 
of thematic analysis. This method enables teams to work 
together to produce a shared (and highly structured) 
analysis drawing across deductive and inductive elements, 
lending itself to multidisciplinary health research.30 Prior 
to data collection, we will ensure a good fit between 
topic guides and the analytic frameworks developed. The 
framework for analysis will incorporate the key theoret-
ical constructs and respond to the context of policy and 
practice to include a range of deductive themes. Further 
themes will be induced from the interview data.
For household interviews, the first draft framework 
will be drawn up using translated interviews in English 
then shared with the team for comment and amend-
ment. The researchers will work together charting inter-
views, comparing their approaches and agreeing the final 
framework. Following this, all remaining interviews in 
Bangla will be charted and translated into the frameworks 
in English. Data familiarisation will be carried out using 
the data matrices produced by this process.
The interviews with HCPs and key informants will be 
analysed using the same principles as household inter-
views and by the same team to identify emerging patterns, 
higher order themes, examining commonalities and 
contradictions in the data. The framing components will 
include a selection of inductive and deductive themes. 
An appropriate balance of integration between empirical 
data and interpretation will be maintained. The investi-
gators will extract the meaning of the empirical data and 
interpret them while acknowledging the complexity of 
the phenomena of antibiotic use in the context.19
ConClusIon
This interdisciplinary study includes public health, policy 
and social and behavioural science approaches to the 
challenges of tackling AMR; supported by the AMR Cross-
Council Initiative theme ‘AMR Within and Beyond the 
Healthcare Setting’. An integrated understanding of the 
behaviours of households, drug sellers and HCPs around 
the sales, purchase and consumption of antibiotics in rural 
and urban Bangladesh is needed to inform stakeholders 
responsible for implementing national actions on antibi-
otic use and consumption. The expected outputs of the 
study include formative data on the relationships between 
households and their local HCPs, motivations for seeking 
or selling antibiotics for people and animals, and knowl-
edge and awareness of how antibiotics work and what 
factors lead to antibiotic resistance. The research will give 
a more comprehensive assessment of the way in which 
antibiotics are used in human and animal domains. The 
research will lead towards the development of potential 
messages and materials for behavioural change commu-
nication to complement future interventions on AMR.
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